Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Immunologic Responses to Vaxchora in Healthy Subjects
NCT03251495Phase 2Completed
- Sponsor
- Emory University
- Start
- Aug 2017
- Primary completion
- Dec 2024
- Modality
- Live Biotherapeutic Products, Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of cholera vaccine, live, oral in cholera, sponsored by Emory University. Primary endpoint: Level of Antibody Titers in Serum at Day 29. Started Aug 2017; status: completed.
02
Drugs
cholera vaccine, live, oral
03
Conditions
cholera
Beyond the preview
Go deeper on NCT03251495.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03251495.